# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Tongue cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 16 results.
Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer
Status: Recruiting
Last Changed: Apr 10, 2019
First Received: Jun 08, 2017
Disease(s): Tongue Cancer
Intervention(s): (18)F-Fluoroazomycin arabinoside, Pimonidazole
Locations: Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer
Status: Recruiting
Last Changed: Jul 29, 2016
First Received: Jul 29, 2016
Disease(s): Recurrent Tongue Cancer
Intervention(s): Cryosurgery, NK immunotherapy
Locations: Fuda cancer institute of Fuda cancer hospital, Guangzhou, Guangdong, China
High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer
Status: Recruiting
Last Changed: Jan 04, 2017
First Received: Jan 02, 2017
Disease(s): Tongue Cancer
Intervention(s): High-activity natural killer
Locations: Fuda cancer institute of Fuda cancer hospital, Guangzhou, Guangdong, China
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
Status: Recruiting
Last Changed: May 24, 2018
First Received: Oct 22, 2015
Disease(s): Tongue Neoplasms, Tongue Cancer, Oral Cancer
Intervention(s): Palatal Augmentation Prosthesis (PAP), Articulation Therapy
Locations: University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry, Ann Arbor, Michigan, United States
Isolation and Establishment of Gustatory Cell Lines in Patients Operated on for Cancer of the Mobile Tongue - ImmortTasteCELL
Status: Recruiting
Last Changed: Oct 09, 2017
First Received: Oct 09, 2017
Disease(s): Cancer of the Tongue
Intervention(s): Sample of cancerous epithelium from the tongue
Locations: Chu Dijon Bourgogne, Dijon, France
A Dye for the Detection of Cancer of the Tongue and Mouth
Status: Recruiting
Last Changed: Apr 03, 2019
First Received: Mar 21, 2017
Disease(s): Oral Squamous Cell Carcinoma (OSCC)
Intervention(s): Olaparib
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
Adjuvant Radiotherapy in Early Stage Oral Cancers
Status: Recruiting
Last Changed: Feb 25, 2019
First Received: Feb 25, 2019
Disease(s): Cancer of Mouth, Cancer of the Tongue, Cancer of the Head and Neck, Buccal Mucosa Cancer, Floor of Mouth Carcinoma
Intervention(s): Post-operative adjuvant radiotherapy
Locations: Dr. B Barooah Cancer Institute, Guwahati, Assam, India
HCG Hospital, Ahmedabad, Gujarat, India
Mazumdar Shaw Medical Centre, Bangalore, Karnataka, India
Amrita Institute of Medical Sciences, Kochi, Kerala, India
Tata Memorial Centre, Mumbai, Maharashtra, India
... and 2 other locations.
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: Jul 26, 2018
Disease(s): HER2-positive Breast Cancer, HER2 Gene Mutation, HER-2 Gene Amplification, HER2 Positive Gastric Cancer, Salivary Gland Cancer, Salivary Gland Tumor, Salivary Gland Carcinoma, Salivary Gland Neoplasms, Lung Cancer, Colo-rectal Cancer, Rare Diseases, Solid Tumor, Recurrent Gastric Cancer, Recurrent Colon Cancer, Recurrent Breast Cancer, Head and Neck Cancer, Head and Neck Carcinoma, Bladder Cancer, Cervical Cancer, Liver Cancer, Bile Duct Cancer, Urologic Cancer, Pancreatic Cancer, Prostate Cancer, Recurrent Prostate Cancer, Rectal Cancer, Recurrent Ovarian Carcinoma, Recurrent Renal Cell Cancer, Rectal Cancer Stage II, Rectal Cancer Stage I, Rectal Cancer Stage III, Skin Cancer, Mouth Cancer, Lip Cancer Stage I, Tongue Cancer, Breast Neoplasm Malignant Primary, Larynx Cancer, Tonsil Cancer, Palate Cancer, Mucoepidermoid Carcinoma, Primary Peritoneal Carcinoma, Mucinous Adenocarcinoma Gastric, Mucinous Breast Cancer Recurrent, Cholangiocarcinoma
Intervention(s): A166
Locations: Florida Cancer Specialists & Research Institute, Sarasota, Florida, United States
Beth Israel Deaconess Medical Center Cancer Center, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Clinical Research Alliance, Inc., Lake Success, New York, United States
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
... and 6 other locations.
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: Sep 19, 2014
Disease(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
Intervention(s): Cytology specimen, Laboratory biomarker analysis
Locations: Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Status: Recruiting
Last Changed: May 23, 2017
First Received: May 06, 2013
Disease(s): Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Tongue Cancer
Intervention(s): carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, fluorouracil, hydroxyurea, therapeutic conventional surgery, radiation therapy, hyperfractionated radiation therapy, laboratory biomarker analysis
Locations: University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States